Proceedings of IMPAACT Annual Meeting 2021 Now Online

Date: 06/30/2021

Publication:

impaactannualmeeting.org

Summary

Convened June 22-24, 2021, the 2021 virtual meeting of the International Maternal Pediatric Adolescent AIDS Clinical Trials Network highlights the latest updates and exciting science in the field, and includes sessions from JHUBI-CTU Co-PIs Drs. Amita Gupta and Charles Flexner.

View Video Presentations

A5225: Phase I/II Dose-Finding Study of High-Dose...

A5225/HiFLAC is a Phase I/II dose escalation and validation study of the safety, tolerability, and therapeutic effect of an...

P2005: A Phase I/II Open-Label, Single-Arm Study to Evaluate...

This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...

The Pharmacokinetics, Safety and Acceptability of New...

PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...

P2001 (DAIDS ID 12026): Evaluating the Pharmacokinetics,...

TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...

A5361s: Pitavastatin to REduce Physical Function Impairment...

A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...